Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(172 Videos)

Research
(1 Videos)
OrthoJoe
(44 Videos)
Webinar
(9 Videos)
OE Headline
(7 Videos)
OrthoPod
(111 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Previous OE Original
Robotic-Assisted Total Hip Arthroplasty: A Meta-analysis of Randomized Controlled Trials
Next OE Original
COVID-19: Long-Lasting Health Effects Among Survivors
OE Original Cover

COVID-19 Vaccines: What Does the Evidence Say about Delaying the Second Dose?

Share
Cite This
+ Favorites
Share
Cite This
+ Favorites
January 18, 2021

COVID-19 Vaccines: What Does the Evidence Say about Delaying the Second Dose?

Vol: 4| Issue: 1| Number:2| ISSN#: 2563-559X

Authored By: Meng Zhu, Mohit Bhandari On Behalf of OrthoEvidence

Banner Image

To view the full content, login to your account,
or start your 30-day FREE Trial today.

FREE TRIAL Forgot Password?

Explore some of our unlocked OE Originals below!

 Evaluation of Clinical and Safety Outcomes of Robotic Arm-assisted Versus Conventional Unicompartmental Knee Arthroplasty: A Systematic Review of Randomized Controlled Trials
Platelet-rich Plasma (PRP) Injection Versus Control for Rotator Cuff Tendinopathy: Powered by OE M.I.N.D.
Surgical Versus Non-surgical Treatment for ACL Injury: Powered by OE M.I.N.D.
Colchicine for Knee Osteoarthritis: A Systematic Review and Meta-analysis
OE OriginalPreview Image

SHARE THIS OE ORIGINAL

Loading...

Recommended OE Originals

Users who read this report also read the following OE Originals:

Join the Conversation

Please Login or Join to leave comments.

HERNÁNDEZ DE LA FUENTE JOSÉ PRÓSPERO 2021-01-19

Resident/Intern - Mexico

ES INDISCUTIBLE QUE LAS PRUEBAS YA ESTABLECIDAS SON EN RELACIÓN A LA APLICACIÓN DE LA SEGUNDA DOSIS A LOS 21 DÍAS, CONSIDERO MAYOR SEGURIDAD Y CERRAR EL CICLO CON CADA INDIVIDUO AL TERMINAR LA APLICACIÓN COMO ESTA LA EVIDENCIA